Snohomish, WA, United States of America

Gregory Paul Darlington

This inventor holds 21 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in High Intensity Focused Ultrasound. Top assignees: Mirabilis Medica, Inc., Liposonix, Inc., Medicis Technologies Corporation. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory Paul Darlington. Retrieved from https://idiyas.com/inventor/gregory-paul-darlington

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 33.3

 

Average Co-Inventor Count = 4.6

ph-index = 11

Forward Citations = 2,038(Granted Patents)


Location History:

  • Snohomoish, WA (US) (2007 - 2012)
  • Snohomish, WA (US) (2011 - 2020)

Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Thermo Sonicator
Plate Handling
Ultrasound Imaging
HIFU Power Deposition
Tissue Treatment
Modular Energy Storage
Feedback Control
Transducer Coupling
Adipose Tissue Destruction
Medical Procedures
Position Tracking
Ultrasound Therapy
21 patents (USPTO):Explore Patents

Title: Gregory Paul Darlington: Innovator in Ultrasound Technology

Introduction

Gregory Paul Darlington is a notable inventor based in Snohomish, WA, recognized for his significant contributions to the field of ultrasound technology. With a portfolio consisting of 19 patents, he has made substantial strides in innovations focused on improving ultrasound imaging and treatment techniques.

Latest Patents

Among his latest patents, Darlington has developed innovative filtering systems and methods aimed at suppressing non-stationary reverberation in ultrasound images. This technology involves a process where an applicator continuously alters its position to change the reverberation artifact ultrasound path length, ultimately resulting in clearer synthesized images. Another of his noteworthy inventions pertains to the optimization and feedback control of High-Intensity Focused Ultrasound (HIFU) power deposition. This system is designed to analyze detected signal characteristics to adjust treatment parameters, thereby enhancing the visualization and effectiveness of HIFU treatments on patient tissue.

Career Highlights

Gregory Darlington has held positions at several prominent companies, including Mirabilis Medica, Inc. and Liposonix, Inc. His work in these organizations has been instrumental in advancing methods and technologies that significantly benefit ultrasound applications.

Collaborations

Throughout his career, Darlington has collaborated with talented individuals such as Jens Ulrich Quistgaard and Justin Reed. These partnerships reflect a dynamic exchange of ideas and expertise that contribute to the innovative progress in their field.

Conclusion

Gregory Paul Darlington stands as an influential figure in ultrasound technology, leveraging his inventive spirit to tackle complex challenges in imaging and treatment. His ongoing contributions continue to pave the way for future advancements in medical applications, enhancing both the capabilities of ultrasound systems and patient care outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…